Marshall Wace
PDSB icon

Marshall Wace’s PDS Biotechnology PDSB Stock Holding History

Marshall Wace’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
+147,171
New +$156K ﹤0.01% 2894
2025
Q3 		– Sell
-68,454
Closed -$91K – 3282
2025
Q2 		$91K Buy
+68,454
New +$93K ﹤0.01% 2553
2025
Q1 		– Sell
-39,024
Closed -$63.6K – 2979
2024
Q4 		$63.6K Buy
39,024
+10,837
+38% +$28.7K ﹤0.01% 2475
2024
Q3 		$108K Buy
+28,187
New +$94K ﹤0.01% 2367
2024
Q2 		– Sell
-41,221
Closed -$163K – 2853
2024
Q1 		$163K Buy
+41,221
New +$212K ﹤0.01% 2260
2023
Q4 		– Sell
-68,795
Closed -$347K – 2501
2023
Q3 		$347K Sell
68,795
-4,425
-6% -$24.2K ﹤0.01% 1834
2023
Q2 		$368K Sell
73,220
-65,788
-47% -$431K ﹤0.01% 2081
2023
Q1 		$855K Buy
139,008
+103,376
+290% +$846K ﹤0.01% 1890
2022
Q4 		$470K Buy
35,632
+8,034
+29% +$56.7K ﹤0.01% 2401
2022
Q3 		$82K Sell
27,598
-49,147
-64% -$209K ﹤0.01% 3206
2022
Q2 		$281K Sell
76,745
-93,734
-55% -$446K ﹤0.01% 3054
2022
Q1 		$1.06M Buy
170,479
+101,550
+147% +$631K ﹤0.01% 2428
2021
Q4 		$557K Buy
68,929
+10,756
+18% +$116K ﹤0.01% 2742
2021
Q3 		$867K Buy
+58,173
New +$725K ﹤0.01% 2105
2021
Q2 		– Sell
-44,232
Closed -$201K – 2976
2021
Q1 		$201K Buy
+44,232
New +$178K ﹤0.01% 2260

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Marshall Wace's PDSB Position: Q2 2026 in Review

Marshall Wace opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 147,171 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #2894 among its holdings. This is a return to the name: Marshall Wace previously reported a position in PDSB as recently as Q2 2025.

Marshall Wace first reported a position in PDSB in Q1 2021 and has held it in 15 quarters since. The position peaked at $1.06M in Q1 2022. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Marshall Wace held 147,171 shares of PDS Biotechnology worth $130K as of Q2 2026.
  • PDS Biotechnology was a new Marshall Wace position in Q2 2026.
  • PDS Biotechnology made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2894 holding.
  • Marshall Wace first reported a position in PDS Biotechnology in Q1 2021 and has held it in 15 quarters since.
  • Marshall Wace's PDS Biotechnology position peaked at $1.06M in Q1 2022.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.